Canada · Delayed Price · Currency is CAD Inozyme Pharma Statistics
Total Valuation
TSXV:TMG has a market cap or net worth of CAD 26.68 million. The enterprise value is 24.31 million.
| Market Cap | 26.68M |
| Enterprise Value | 24.31M |
Important Dates
The next estimated earnings date is Thursday, September 25, 2025.
| Earnings Date | Sep 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSXV:TMG has 172.10 million shares outstanding. The number of shares has increased by 5.34% in one year.
| Current Share Class | 172.10M |
| Shares Outstanding | 172.10M |
| Shares Change (YoY) | +5.34% |
| Shares Change (QoQ) | +43.04% |
| Owned by Insiders (%) | 9.02% |
| Owned by Institutions (%) | 1.11% |
| Float | 156.57M |
Valuation Ratios
The trailing PE ratio is 174.22.
| PE Ratio | 174.22 |
| Forward PE | n/a |
| PS Ratio | 0.88 |
| PB Ratio | 7.59 |
| P/TBV Ratio | 8.84 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.46, with an EV/FCF ratio of -34.50.
| EV / Earnings | 158.76 |
| EV / Sales | 0.80 |
| EV / EBITDA | 20.46 |
| EV / EBIT | 59.54 |
| EV / FCF | -34.50 |
Financial Position
The company has a current ratio of 1.24, with a Debt / Equity ratio of 0.80.
| Current Ratio | 1.24 |
| Quick Ratio | 0.97 |
| Debt / Equity | 0.80 |
| Debt / EBITDA | 2.36 |
| Debt / FCF | -3.98 |
| Interest Coverage | 1.24 |
Financial Efficiency
Return on equity (ROE) is 6.89% and return on invested capital (ROIC) is 3.77%.
| Return on Equity (ROE) | 6.89% |
| Return on Assets (ROA) | 1.62% |
| Return on Invested Capital (ROIC) | 3.77% |
| Return on Capital Employed (ROCE) | 8.97% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.94 |
| Inventory Turnover | 10.05 |
Taxes
| Income Tax | -45,675 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.19% in the last 52 weeks. The beta is 0.26, so TSXV:TMG's price volatility has been lower than the market average.
| Beta (5Y) | 0.26 |
| 52-Week Price Change | -26.19% |
| 50-Day Moving Average | 0.15 |
| 200-Day Moving Average | 0.16 |
| Relative Strength Index (RSI) | 51.53 |
| Average Volume (20 Days) | 56,205 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSXV:TMG had revenue of CAD 30.48 million and earned 153,111 in profits. Earnings per share was 0.00.
| Revenue | 30.48M |
| Gross Profit | 11.80M |
| Operating Income | 408,298 |
| Pretax Income | 179,181 |
| Net Income | 153,111 |
| EBITDA | 819,809 |
| EBIT | 408,298 |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 5.14 million in cash and 2.81 million in debt, giving a net cash position of 2.34 million or 0.01 per share.
| Cash & Cash Equivalents | 5.14M |
| Total Debt | 2.81M |
| Net Cash | 2.34M |
| Net Cash Per Share | 0.01 |
| Equity (Book Value) | 3.52M |
| Book Value Per Share | 0.02 |
| Working Capital | 2.38M |
Cash Flow
In the last 12 months, operating cash flow was -609,265 and capital expenditures -95,362, giving a free cash flow of -704,627.
| Operating Cash Flow | -609,265 |
| Capital Expenditures | -95,362 |
| Free Cash Flow | -704,627 |
| FCF Per Share | -0.00 |
Margins
Gross margin is 38.71%, with operating and profit margins of 1.34% and 0.50%.
| Gross Margin | 38.71% |
| Operating Margin | 1.34% |
| Pretax Margin | 0.59% |
| Profit Margin | 0.50% |
| EBITDA Margin | 2.69% |
| EBIT Margin | 1.34% |
| FCF Margin | n/a |
Dividends & Yields
TSXV:TMG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.34% |
| Shareholder Yield | n/a |
| Earnings Yield | 0.57% |
| FCF Yield | -2.64% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TSXV:TMG has an Altman Z-Score of 1.18 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.18 |
| Piotroski F-Score | 4 |